Literature DB >> 32433235

Live Donor Liver Transplantation in the United States: Impact of Share 35 on Live Donor Utilization.

Hillary J Braun1, Jennifer L Dodge1, Joshua D Grab1, Marisa E Schwab1, Iris H Liu1, Alexa C Glencer1, Peter G Stock1, Ryutaro Hirose1, John P Roberts1, Nancy L Ascher1.   

Abstract

BACKGROUND: Share 35 was a policy implemented in 2013 to increase regional sharing of deceased donor livers to patients with model for end-stage liver disease ≥ 35 to decrease waitlist mortality for the sickest patients awaiting liver transplantation (LT). The purpose of this study was to determine whether live donor liver transplantation (LDLT) volume was impacted by the shift in allocation of deceased donor livers to patients with higher model for end-stage liver disease scores.
METHODS: Using Network for Organ Sharing/Organ Procurement and Transplantation Network Standard Transplant Analysis and Research files, we identified all adults who received a primary LT between October 1, 2008, and March 31, 2018. LT from October 1, 2008, through June 30, 2013, was designated as the pre-Share 35 era and July 1, 2013, through March 31, 2018, as the post-Share 35 era. Primary outcomes included transplant volumes, graft survival, and patient survival in both eras.
RESULTS: In total, 48 779 primary adult single-organ LT occurred during the study period (22 255 pre-Share 35, 26 524 post). LDLT increased significantly (6.8% post versus 5.7% pre, P < 0.001). LDLT volume varied significantly by region (P < 0.001) with regions 2, 4, 5, and 8 demonstrating significant increases in LDLT volume post-Share 35. The number of centers performing LDLT increased only in regions 4, 6, and 11. Throughout the 2 eras, there was no difference in graft or patient survival for LDLT recipients.
CONCLUSIONS: Overall, LDLT volume increased following the implementation of Share 35, which was largely due to increased LDLT volume at centers with experience in LDLT, and corresponded to significant geographic variation in LDLT utilization.
Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2021        PMID: 32433235      PMCID: PMC7980785          DOI: 10.1097/TP.0000000000003318

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   5.385


  11 in total

1.  Same policy, different impact: Center-level effects of share 35 liver allocation.

Authors:  Douglas R Murken; Allison W Peng; David D Aufhauser; Peter L Abt; David S Goldberg; Matthew H Levine
Journal:  Liver Transpl       Date:  2017-06       Impact factor: 5.799

2.  Geographic Disparity in Deceased Donor Liver Transplant Rates Following Share 35.

Authors:  Mary G Bowring; Sheng Zhou; Eric K H Chow; Allan B Massie; Dorry L Segev; Sommer E Gentry
Journal:  Transplantation       Date:  2019-10       Impact factor: 4.939

3.  Multiple listings as a reflection of geographic disparity in liver transplantation.

Authors:  Parsia A Vagefi; Sandy Feng; Jennifer L Dodge; James F Markmann; John P Roberts
Journal:  J Am Coll Surg       Date:  2014-05-02       Impact factor: 6.113

4.  Geographic inequity in access to livers for transplantation.

Authors:  Heidi Yeh; Elizabeth Smoot; David A Schoenfeld; James F Markmann
Journal:  Transplantation       Date:  2011-02-27       Impact factor: 4.939

Review 5.  Is living donor liver transplantation justified in high model for end-stage liver disease candidates (35+)?

Authors:  Kin P Au; Albert C Y Chan
Journal:  Curr Opin Organ Transplant       Date:  2019-10       Impact factor: 2.640

6.  The impact of broader regional sharing of livers: 2-year results of "Share 35".

Authors:  Erick B Edwards; Ann M Harper; Ryutaro Hirose; David C Mulligan
Journal:  Liver Transpl       Date:  2016-04       Impact factor: 5.799

7.  Improved posttransplant mortality after share 35 for liver transplantation.

Authors:  Allison J Kwong; Aparna Goel; Ajitha Mannalithara; W Ray Kim
Journal:  Hepatology       Date:  2017-11-13       Impact factor: 17.425

Review 8.  Current Status of Living Donor Liver Transplantation in the United States.

Authors:  Samir Abu-Gazala; Kim M Olthoff
Journal:  Annu Rev Med       Date:  2018-10-24       Impact factor: 13.739

9.  Waitlist Outcomes of Liver Transplant Candidates Who Were Reprioritized Under Share 35.

Authors:  E K H Chow; A B Massie; X Luo; C E Wickliffe; S E Gentry; A M Cameron; D L Segev
Journal:  Am J Transplant       Date:  2016-08-24       Impact factor: 8.086

Review 10.  Living donor liver transplantation in the USA.

Authors:  Peter T W Kim; Giuliano Testa
Journal:  Hepatobiliary Surg Nutr       Date:  2016-04       Impact factor: 7.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.